(NYSE: BMY) Bristol Myers Squibb's forecast annual revenue growth rate of 5.16% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 5.95%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 15.05%.
Bristol Myers Squibb's revenue in 2021 is $42,518,000,000.On average, 5 Wall Street analysts forecast BMY's revenue for 2021 to be $103,911,871,463,348, with the lowest BMY revenue forecast at $102,994,050,786,797, and the highest BMY revenue forecast at $104,540,624,725,716. On average, 5 Wall Street analysts forecast BMY's revenue for 2022 to be $108,040,175,355,558, with the lowest BMY revenue forecast at $105,672,669,846,173, and the highest BMY revenue forecast at $110,694,380,059,534.
In 2023, BMY is forecast to generate $111,732,035,359,084 in revenue, with the lowest revenue forecast at $110,149,327,993,392 and the highest revenue forecast at $115,156,937,357,280.